NCT04249414

Post-hoc Analysis of Regional Pulmonary Perfusion and Hemodynamic Parameters Measured by Electrical Impedance Tomography

• Status: Suspended
• Phase: —
• Study type: Observational
• Enrollment: 22 (estimated)
• Sponsor: Drägerwerk AG & Co. KGaA · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Define the capability and reliability of the PulmoVista® 500 (PV500) to detect changes in global and regional ventilation and perfusion.

Detailed description

The results of this study will help defining the capability and reliability of PulmoVista® 500 (PV500) to detect changes in both global and regional ventilation and perfusion. As this is a non-invasive, observational trial, neither a positive nor a negative impact on the actual study participants is expected. The results will, however, improve the knowledge about the electrical impedance tomography (EIT) technology and thus aid the use of this technology for the benefit of future patients.

Conditions

• Mechanical Ventilation
• Ventilation Perfusion Mismatch

Interventions

Type	Name	Description
DEVICE	PulmoVista 500	Monitoring of Ventilation and Perfusion with the PulmoVista 500 during clinical routine. No medical interventions required

Timeline

• Start date: 2024-01-01
• Primary completion: 2024-06-01
• Completion: 2024-12-01
• First posted: 2020-01-31
• Last updated: 2023-03-06

Locations

1 site across 1 country: Germany